Clinical decision-making in the treatment of schizophrenia: focus on long-acting injectable antipsychotics

HIGHLIGHTS

  • who: Ludovic Samalin et al. from the Centre Hospitalier et Universitaire, Department of Psychiatry, University of Auvergne, EA, Paris, France have published the paper: Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics, in the Journal: (JOURNAL)
  • what: The aim of this study was to identify clinician characteristics associated with higher prescription rates of_(LAI) as well as the sources that influence medical decision-making regarding the treatment of The primary reasons given for the non-use of guidelines by French psychiatrists were related to the cultural differences between Anglo . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?